<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To identify the <z:hpo ids='HP_0003074'>Hyperglycemia</z:hpo> and Its Effect After <z:hpo ids='HP_0011009'>Acute</z:hpo> <z:hpo ids='HP_0001658'>Myocardial Infarction</z:hpo> on Cardiovascular Outcomes in Patients With Type 2 <z:hpo ids='HP_0000819'>Diabetes Mellitus</z:hpo> (HEART2D) trial subgroups with treatment difference </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: In 1,115 type 2 diabetic patients who had suffered from an <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e>), the HEART2D trial compared two insulin strategies targeting postprandial or fasting/premeal glycemia on time until first cardiovascular event (cardiovascular <z:hpo ids='HP_0011420'>death</z:hpo>, nonfatal MI, nonfatal <z:hpo ids='HP_0001297'>stroke</z:hpo>, coronary revascularization, or hospitalization for <z:hpo ids='HP_0011009'>acute</z:hpo> coronary syndrome) </plain></SENT>
<SENT sid="2" pm="."><plain>The HEART2D trial ended prematurely for futility </plain></SENT>
<SENT sid="3" pm="."><plain>We used the classification and regression tree (CART) to identify baseline subgroups with potential treatment differences </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: CART estimated the age of &gt;65.7 years to best predict the difference in time to first event </plain></SENT>
<SENT sid="5" pm="."><plain>In the subgroup aged&gt;65.7 years (prandial, n=189; basal, n=210), prandial patients had a significantly longer time to first event and a lower proportion experienced a first event (n=56 [29.6%] vs. n=85 [40.5%]; hazard ratio 0.69 [95% CI 0.49-0.96]; P=0.029), despite similar A1C levels </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: Older type 2 diabetic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e> survivors may have a lower risk for a subsequent cardiovascular event with insulin targeting postprandial versus fasting/premeal glycemia </plain></SENT>
</text></document>